ArticleTherapeutic advances in medical oncology2020

Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide.

Konstantin Byrgazov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.